Alemtuzumab: a review of efficacy and risks in the treatment of relapsing remitting multiple sclerosis

Cristina Guarnera, Placido Bramanti, Emanuela Mazzon Experimental Neurology Laboratory, IRCCS Centro Neurolesi “Bonino-Pulejo”, Via Provinciale Palermo, Contrada Casazza, Messina, Italy Abstract: Alemtuzumab is a selective humanized monoclonal antibody directed against the CD52 a...

Full description

Saved in:
Bibliographic Details
Main Authors: Guarnera C (Author), Bramanti P (Author), Mazzon E (Author)
Format: Book
Published: Dove Medical Press, 2017-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available